Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -75,850 | -45,573 | -20,999 | -83,724 | -57,943 |
| Depreciation Amortization | -4,285 | -3,265 | -1,781 | -2,218 | 11 |
| Accounts payable and accrued liabilities | -7,268 | 1,202 | -5,122 | 3,462 | 7,978 |
| Other Working Capital | -5,925 | -5,323 | -3,034 | 11,591 | 7,611 |
| Other Operating Activity | 27,712 | 8,945 | 10,067 | 13,052 | 3,324 |
| Operating Cash Flow | $-65,616 | $-44,014 | $-20,869 | $-57,837 | $-39,019 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -146 | -47 | -13 | -189 | -171 |
| Purchase Of Investment | -419,972 | -152,289 | -44,290 | -329,938 | N/A |
| Sale Of Investment | 345,395 | 200,062 | 87,169 | N/A | N/A |
| Investing Cash Flow | $-74,723 | $47,726 | $42,866 | $-330,127 | $-171 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 24,980 | 24,980 |
| Common Stock Issued | 109 | 109 | N/A | 54 | N/A |
| Other Financing Activity | 169,908 | 0 | 0 | 424,505 | 425,085 |
| Financing Cash Flow | $170,017 | $109 | $N/A | $449,539 | $450,065 |
| Beginning Cash Position | 61,575 | 61,575 | 61,575 | N/A | N/A |
| End Cash Position | 91,253 | 65,396 | 83,572 | 61,575 | 410,875 |
| Net Cash Flow | $29,678 | $3,821 | $21,997 | $61,575 | $410,875 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,616 | -44,014 | -20,869 | -57,837 | -39,019 |
| Capital Expenditure | -146 | -47 | -13 | -189 | -171 |
| Free Cash Flow | -65,762 | -44,061 | -20,882 | -58,026 | -39,190 |